March 29, 2025 at 4:30 PM
Stephan Windecker discusses 5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis
#ACC25 #ESCTVOnTheRoad
#ACC25 #ESCTVOnTheRoad
March 30, 2025 at 6:45 PM
Stephan Windecker discusses 5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis
#ACC25 #ESCTVOnTheRoad
#ACC25 #ESCTVOnTheRoad
March 30, 2025 at 4:58 PM
March 29, 2025 at 9:01 PM
March 29, 2025 at 9:14 PM
March 30, 2025 at 10:19 PM
#ESCTVOntheRoad 🚍 at #ACC25
Marco Valgimigli discusses stratified randomisation study to compare different duration of dual antiplatelet therapy after coronary stenting in either high or low bleeding risk population
Marco Valgimigli discusses stratified randomisation study to compare different duration of dual antiplatelet therapy after coronary stenting in either high or low bleeding risk population
March 29, 2025 at 6:07 PM
#ESCTVOntheRoad 🚍 at #ACC25
Marco Valgimigli discusses stratified randomisation study to compare different duration of dual antiplatelet therapy after coronary stenting in either high or low bleeding risk population
Marco Valgimigli discusses stratified randomisation study to compare different duration of dual antiplatelet therapy after coronary stenting in either high or low bleeding risk population
March 30, 2025 at 5:49 PM
#ESCTVOntheRoad 🚍 at #AHA25
Eugenia Gianos shares groundbreaking insights from the primary findings of the VESALIUS-CV Trial.
Eugenia Gianos shares groundbreaking insights from the primary findings of the VESALIUS-CV Trial.
November 8, 2025 at 8:36 PM
#ESCTVOntheRoad 🚍 at #AHA25
Eugenia Gianos shares groundbreaking insights from the primary findings of the VESALIUS-CV Trial.
Eugenia Gianos shares groundbreaking insights from the primary findings of the VESALIUS-CV Trial.
ESC President, Tom Lüscher, highlights key takeaways From the SOUL Randomised Trial
#ESCTVOntheRoad #ACC25
#ESCTVOntheRoad #ACC25
March 29, 2025 at 7:50 PM
ESC President, Tom Lüscher, highlights key takeaways From the SOUL Randomised Trial
#ESCTVOntheRoad #ACC25
#ESCTVOntheRoad #ACC25
Listen to Pavel Osmancik as he shares his take-away message on the PRAGUE-25 Study
#ACC25 #ESCTVOnTheRoad
#ACC25 #ESCTVOnTheRoad
March 30, 2025 at 8:20 PM
Listen to Pavel Osmancik as he shares his take-away message on the PRAGUE-25 Study
#ACC25 #ESCTVOnTheRoad
#ACC25 #ESCTVOnTheRoad
🎥 Hear from Roxana Mehran as she breaks down the key findings and clinical implications of the DECAF Trial – straight from #AHA25
#ESCTVOntheRoad
#ESCTVOntheRoad
November 9, 2025 at 3:53 PM
🎥 Hear from Roxana Mehran as she breaks down the key findings and clinical implications of the DECAF Trial – straight from #AHA25
#ESCTVOntheRoad
#ESCTVOntheRoad
Prashanthan Sanders shares his perspective on the DARE-AF Randomized Clinical Trial at #AHA25
#ESCTVOntheRoad
#ESCTVOntheRoad
November 9, 2025 at 4:54 PM
Prashanthan Sanders shares his perspective on the DARE-AF Randomized Clinical Trial at #AHA25
#ESCTVOntheRoad
#ESCTVOntheRoad
November 8, 2025 at 10:01 PM
Victoria Delgado highlights key takeaways from the Final Outcomes of the RECOVERY Trial at #AHA25
#ESCTVOntheRoad
#ESCTVOntheRoad
November 9, 2025 at 3:05 PM
Victoria Delgado highlights key takeaways from the Final Outcomes of the RECOVERY Trial at #AHA25
#ESCTVOntheRoad
#ESCTVOntheRoad
ESC President Thomas Lüscher offers his insights and take-home message on the OCEAN Randomized Trial
#ESCTVOntheRoad 🚍 at #AHA25
#ESCTVOntheRoad 🚍 at #AHA25
November 8, 2025 at 9:57 PM
ESC President Thomas Lüscher offers his insights and take-home message on the OCEAN Randomized Trial
#ESCTVOntheRoad 🚍 at #AHA25
#ESCTVOntheRoad 🚍 at #AHA25
Josephine Harrington breaks down the results of the POLY-HF Trial, exploring how a polypill strategy could transform treatment for patients with reduced ejection fraction.
#ESCTVOntheRoad #AHA25
#ESCTVOntheRoad #AHA25
November 10, 2025 at 6:32 PM
Josephine Harrington breaks down the results of the POLY-HF Trial, exploring how a polypill strategy could transform treatment for patients with reduced ejection fraction.
#ESCTVOntheRoad #AHA25
#ESCTVOntheRoad #AHA25
Join John McMurray as he discusses the SURPASS-CVOT Trial on #ESCTVOnTheRoad – key takeaways, clinical insights, and what this means for the future of cardiovascular care.
#AHA25
#AHA25
November 10, 2025 at 6:12 PM
Join John McMurray as he discusses the SURPASS-CVOT Trial on #ESCTVOnTheRoad – key takeaways, clinical insights, and what this means for the future of cardiovascular care.
#AHA25
#AHA25